Malignant Supratentorial Neoplasm — Trials

Malignant Supratentorial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

84 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 24
Recruiting: 18
Ph III recruiting: 0
Growth YoY: —
Industry share: 4%
Top sponsor: Children's National Research Institute
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05457959	Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant	withdrawn	Phase 1	0	Jonsson Comprehensive Cancer CenterOTHER	1	Feb 24, 2025	clinicaltrials
NCT03990597	StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord	withdrawn	Phase 1	0	M.D. Anderson Cancer CenterOTHER	1	Oct 9, 2024